Psychological effect, pathophysiology, and management of androgenetic alopecia in men

Mayo Clinic Proceedings

Volumn 80, Issue 10, 2005, Pages 1316-1322

  Stough, Dow ^a   Stenn, Kurt ^b   Haber, Robert ^c   Parsley, William M ^d   Vogel, James E ^e   Whiting, David A ^f   Washenik, Ken ^g  

^a Stough Clinic   (United States)

^b Aderans Research Institute Inc   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BAYLOR HEALTH CARE SYSTEM   (United States)

^g Bosley Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; DUTASTERIDE; FINASTERIDE; MINOXIDIL; POTASSIUM CHANNEL STIMULATING AGENT; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE;

ANAMNESIS; BIOPSY; BODY IMAGE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; GENETIC PREDISPOSITION; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INJURY; IRRITANT DERMATITIS; LIBIDO DISORDER; MALE TYPE ALOPECIA; ONSET AGE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREVALENCE; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; SEXUAL DYSFUNCTION; SKIN ALLERGY; SOCIAL PSYCHOLOGY; SUNBURN; ULTRAVIOLET RADIATION;

EID: 25844515594     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.10.1316     Document Type: Conference Paper

References (45)

1. Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141:398-405.
2. Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol. 2001;19:161-166.
3. Messenger AG. Medical management of male pattern hair loss. Int J Dermatol. 2000;39:585-586.
4. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4:1-11.
5. Feinstein R. Androgenetic alopecia. Available at: www.emedicine.com/derm/ topic21.htm. Accessibility verified August 8, 2005.
6. Norwood OT. Hair Transplant Surgery. Springfield, Ill: Charles C Thomas; 1973:3-16.
7. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53:708-728.
8. Birch MP, Messenger AG. Genetic factors predispose to balding and non-balding in men. Eur J Dermatol. 2001;11:309-314.
9. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52:301-311.
10. Budd D, Himmelberger D, Rhodes T, Cash TE, Girman CJ. The effects of hair loss in European men: a survey in four countries. Eur J Dermatol. 2000;10:122-127.
11. Wells PA, Willmoth T, Russell RJ. Does fortune favour the bald? psychological correlates of hair loss in males. Br J Psychol. 1995;86(pt 3):337-344.
12. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol. 1992;26:926-931.
13. Gosselin C. Hair loss, personality and attitudes. Pers Individ Dif. 1984;5:365-369.
14. van der Donk J, Passchier J, Dutree-Meulenberg RO, Stolz E, Verhage F. Psychologic characteristics of men with alopecia androgenetica and their modification. Int J Dermatol. 1991;30:22-28.
15. Girman CJ, Rhodes T, Lilly FR, et al. Effects of self-perceived hair loss in a community sample of men. Dermatology. 1998;197:223-229.
16. Goh CL. A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Centre, a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore. 2002;31:751-755.
17. Roll S, Verinis JS. Stereotypes of scalp and facial hair as measured by the semantic differential. Psychol Rep. 1971;28:975-980.
18. Moerman DE. The meaning of baldness and implications for treatment. Clin Dermatol. 1988;6:89-92.
19. Cash TF. Losing hair, losing points? the effects of male pattern baldness on social impression formation. J Appl Soc Psychol. 1990;20(2, pt 1):154-167.
20. Whiting DA. Male pattern hair loss: current understanding. Int J Dermatol. 1998;37:561-566.
21. Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol. 2001;45(3, suppl): S81-S86.
22. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia [published correction appears in J Am Acad Dermatol. 1993;29:554]. J Am Acad Dermatol. 1993;28(5, pt 1):755-763.
23. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198:89-95.
24. Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia. Eur Urol. 2000;37:367-380.
25. Hamilton JB. Male hormone stimulation is prerequisite and incitant in common baldness. Am J Anat. 1942;71:451-480.
26. Griffin JE, Wilson JD. The androgen resistance syndromes: 5α-reductase deficiency, testicular feminization, and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. Vol 2. 6th ed. New York, NY: McGraw-Hill; 1989:1919-1944.
27. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186:1213-1215.
28. Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones, II: androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;39:1012-1019.
29. Sawaya ME,Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109:296-300.
30. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ III. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70:628-633.
31. Saraswat A, Kumar B. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia [letter]. Arch Dermatol. 2003;139:1219-1221.
32. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150:186-194.
33. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47:377-385.
34. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 1999;41(5, pt 1): 717-721.
35. Olsen EA, Weiner MS. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol. 1987;17:97-101.
36. Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46:309-312.
37. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. l999;41:550-554.
38. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc. 1999;4:282-284.
39. Kaufman KD, Olsen EA, Whiting D, et al, Finasteride Male Pattern Hair Loss Study Group. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4,pt 1):578-589.
40. Whiting DA, Olsen EA, Savin R, et al, Male Pattern Hair Loss Study Group. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol. 2003;13:150-160.
41. Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12:38-49.
42. Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40(6, pt 1):930-937.
43. Andriole GL, Guess HA, Epstein JI, et al, PLESS Study Group. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. Urology. 1998;52:195-201.
44. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-224.
45. Limmer BL. Hair transplantation: follicular unit transplant method. Available at: www.emedicine.com/derm/topic559.htm. Accessibility verified August 9, 2005.